Johnson & Johnson
JNJ
$145.74
$0.970.67%
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 01/01/2023 | |
|---|---|---|---|---|---|
| Revenue | 21.40B | 21.35B | 17.67B | 24.75B | 19.94B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 21.40B | 21.35B | 17.67B | 24.75B | 19.94B |
| Cost of Revenue | 6.72B | 6.38B | 4.95B | 8.20B | 6.08B |
| Gross Profit | 14.68B | 14.97B | 12.71B | 16.55B | 13.86B |
| SG&A Expenses | 5.47B | 5.10B | 3.81B | 5.79B | 5.05B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.67B | 14.93B | 12.36B | 17.55B | 14.84B |
| Operating Income | 4.73B | 6.42B | 5.31B | 7.20B | 5.10B |
| Income Before Tax | 4.83B | 5.22B | 5.76B | -737.00M | 3.84B |
| Income Tax Expenses | 694.00M | 908.00M | 803.00M | -669.00M | 613.00M |
| Earnings from Continuing Operations | 4.13B | 4.31B | 4.95B | -68.00M | 3.23B |
| Earnings from Discontinued Operations | -83.00M | 21.72B | -- | -- | 293.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.05B | 26.03B | 5.14B | -68.00M | 3.52B |
| EBIT | 4.73B | 6.42B | 5.31B | 7.20B | 5.10B |
| EBITDA | 6.19B | 8.25B | 7.25B | 9.08B | 6.23B |
| EPS Basic | 1.46 | 10.32 | 1.98 | -0.03 | 1.35 |
| Normalized Basic EPS | 1.07 | 1.66 | 1.57 | 1.80 | 1.45 |
| EPS Diluted | 1.46 | 10.21 | 1.96 | -0.03 | 1.32 |
| Normalized Diluted EPS | 1.07 | 1.64 | 1.54 | 1.80 | 1.43 |
| Average Basic Shares Outstanding | 2.77B | 2.52B | 2.60B | 2.61B | 2.63B |
| Average Diluted Shares Outstanding | 2.77B | 2.55B | 2.63B | 2.61B | 2.66B |
| Dividend Per Share | 1.19 | 1.19 | 1.19 | 1.13 | 1.13 |
| Payout Ratio | 70.76% | -- | 118.87% | -4,326.47% | 65.11% |
